Predictors of response to combination therapy with recombinant Factor VIIa and Factor VIII in patients with hemophilia A and high titer inhibitors

被引：0
|
作者：
Dunn, Amy L. [1 ]
Nguyen, Brenda [1 ]
Baldwin, W. Hunter [1 ]
Kenet, Gili [2 ,3 ]
Meeks, Shannon L. [1 ]
机构：
[1] Emory Univ, Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA
[2] Chaim Sheba Med Ctr, Israeli Natl Hemophilia Ctr, IL-52621 Tel Hashomer, Israel
[3] Chaim Sheba Med Ctr, Thrombosis Unit, IL-52621 Tel Hashomer, Israel
来源：
HAEMOPHILIA | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [1] High-dose recombinant factor VIIa therapy in hemophilia patients with inhibitors
    Kenet, G
    SEMINARS IN HEMATOLOGY, 2006, 43 (01) : S108 - S110
  • [2] Efficacy and safety of continuous infusion of recombinant factor VIIa in pediatric hemophilia A patients with high titer inhibitors.
    Ettingshausen, CE
    Auerswald, G
    Auberger, K
    Saguer, IM
    Kreuz, W
    BLOOD, 1999, 94 (10) : 238A - 238A
  • [3] Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency
    Scharrer, I
    HAEMOPHILIA, 1999, 5 (04) : 253 - 259
  • [4] Factor VIII supplementation improves hemophilia a thrombin generation in the presence of FVIII inhibitors and recombinant factor VIIa
    Meeks, S. L.
    Gangadharan, B.
    Doering, C. B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 686 - 687
  • [5] Successful treatment of high titer inhibitors in mild hemophilia a with avoidance of factor VIII and immunosuppressive therapy
    Robbins, D
    Kulkarni, R
    Gera, R
    Scott-Emuakpor, AB
    Bosma, K
    Penner, JA
    AMERICAN JOURNAL OF HEMATOLOGY, 2001, 68 (03) : 184 - 188
  • [6] USE OF HUMAN FACTOR-VIIA IN THE TREATMENT OF 2 HEMOPHILIA A PATIENTS WITH HIGH-TITER INHIBITORS
    HEDNER, U
    KISIEL, W
    JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (06): : 1836 - 1841
  • [7] The Mayo Clinic surgical experience, with recombinant factor VIIa (rFVIIa) in patients with congenital hemophilia A (HA) and B (HB) and high titer inhibitors
    Gastineau, DA
    Pruthi, RK
    Moir, CR
    Bolander, ME
    Shaughnessy, WJ
    Farnell, MB
    Koenig, BK
    Gilchrist, GS
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS207 - PS207
  • [8] Effects of recombinant factor VIIa (NovoSeven®) on restoring thrombin generation in patients with hemophilia a and antibodies to factor VIII
    Eichinger, Sabine
    Lubszcyk, Barbara
    Zwiauer, Karl
    Gleiss, Andreas
    Quehenberger, Peter
    Kyrle, Paul Alexander
    BLOOD, 2007, 110 (11) : 352A - 352A
  • [9] Effects of recombinant factor VIIa (NovoSeven®) on restoring thrombin generation in patients with hemophilia A and antibodies to factor VIII
    Eichinger, S.
    Lubsczyk, B.
    Zwiauer, K.
    Gleiss, A.
    Quehenberger, P.
    Kyrle, P.
    HAEMOPHILIA, 2008, 14 : 45 - 45
  • [10] Thrombelastgram as a hemostatic monitor during recombinant factor VIIa treatment in hemophilia A patients with inhibitor to factor VIII
    Yoshioka, A
    Nishio, K
    Shima, M
    HAEMOSTASIS, 1996, 26 : 139 - 142
12345